🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Forrest Gordon

Teva Pharmaceuticals (United States)

ORCID: 0000-0002-0271-3050

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome”.

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.29397

N/A

0DataRank · unranked

40 citations

Joseph Jankovic, Daniel O. Claassen, Joohi Jimenez‐Shahed, Barry J. Gertz, Elizabeth A. Garofalo +8 more

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study

Frontiers in Neurology(2022)10.3389/fneur.2022.773999

N/A

0DataRank · unranked

13 citations

Hadas Barkay, Hubert H. Fernandez, Stewart A. Factor, Joohi Jimenez‐Shahed, Nicholas J. Gross +7 more

Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study

Movement Disorders(2023)10.1002/mds.29633

N/A

0DataRank · unranked

30 citations

Patrice Péran, Vincent Beliveau, Klaus Seppi, Germain Arribarat, Anne Pavy‐Le Traon +10 more